Whey protein: The &ldquo;whey&rdquo; forward for treatment of type 2 diabetes?

doi:10.4239/wjd.v6.i14.1274

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 14

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (22192)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series.

Item

Count

PDF

1307

WORD

570

HTML

14516

Figures (1-1)

287

Sum=16680

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

620

Download

1507

Sum=2127

Publishing Process of This Article

Item

Count

Browse

1323

Download

2062

Sum=3385

Oct 25, 2015 (publication date) through Feb 1, 2025

Times Cited of This Article

Times Cited (68)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Diabetes. Oct 25, 2015; 6(14): 1274-1284
Published online Oct 25, 2015. doi: 10.4239/wjd.v6.i14.1274

Full Size Figure Download Figure

Figure 1 Mechanisms by which whey protein can reduce postprandial glycaemia. GLP-1: Glucagon-like-peptide-1; GIP: Glucose-dependent insulinotropic polypeptide; CCK: Cholecystokinin; PYY: Peptide YY; DPP-IV: Dipeptidyl peptidase-IV.

Citation: Mignone LE, Wu T, Horowitz M, Rayner CK. Whey protein: The “whey” forward for treatment of type 2 diabetes? World J Diabetes 2015; 6(14): 1274-1284
URL: https://www.wjgnet.com/1948-9358/full/v6/i14/1274.htm
DOI: https://dx.doi.org/10.4239/wjd.v6.i14.1274